Procter & Gamble Recalls Vicks Sinex Nasal Spray
Procter & Gamble Co. said it is voluntarily recalling three lots of Vicks Sinex nasal spray because of potential bacterial contamination.
The Cincinnati-based company said it discovered the bacteria B. cepacia in the nasal spray made in its Gross Gerau, Germany plant. The bacteria has the potential to cause serious infections in people with immune system conditions and lung conditions. No illnesses have been reported.
The recall covers the U.S., Britain and Germany.
In the U.S., the recall affects lot 9239028831 Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist, 15 milliliters Nasal Spray.
In the United Kingdom, the company is recalling lot 9224028832 Vicks Sinex Micromist Aqueous Nasal Spray Solution, 15 milliliters. In Germany, it is recalling 9224028833 Wick Sinex Schnupfenspray Dosiersystem, 15 milliliters.
Anyone who has these specific lots can call P&G for a replacement coupon or refund at 1-877-876-7881 in the U.S.
Shares of P&G fell 49 cents to $61.92 in afternoon trading.
- Warren Buffett’s PacifiCorp Now Faces $30 Billion Fire Claim Demand
- Chubb CEO Greenberg: Some Financial Lines Underwriting Practices ‘Simply Dumb’
- Work Safety Group Releases List of ‘Dirty Dozen’ Employers
- Florida’s Home Insurance Industry May Be Worse Than Anyone Realizes
- CoreLogic Report Probes Evolving Severe Convective Storm Risk Landscape
- Millions of Recalled Hyundai and Kia Vehicles, With Dangerous Defect, Remain on Road
- EVs Head for Junkyard as Mechanic Shortage Inflates Repair Costs
- Report: Vehicle Complexity, Labor ‘Reshaping’ Auto Insurance and Collision Repair